Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9501-9550 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05270668
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)
PHASE2Active, not recruiting
154 participants
Started: Mar 29, 2022 · Completed: Jul 31, 2029
2 conditions1 sponsor95 locations
NCT05348915
A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease
PHASE3Active, not recruiting
147 participants
Started: Mar 29, 2022 · Completed: Nov 4, 2028
3 conditions1 sponsor49 locations
NCT05163808
A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
PHASE2/PHASE3Active, not recruiting
163 participants
Started: Mar 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor17 locations
NCT04645147
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
PHASE1Active, not recruiting
83 participants
Started: Mar 29, 2022 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT05244304
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
PHASE3Active, not recruiting
104 participants
Started: Mar 28, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor19 locations
NCT05886504
Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users
NAActive, not recruiting
567 participants
Started: Mar 28, 2022 · Completed: Jul 28, 2024
2 conditions5 sponsors1 location
NCT05167201
Domiciliary Nasal High Flow and Patient Outcomes in Chronic Hypercapnic Respiratory Failure in the United Kingdom
NAActive, not recruiting
54 participants
Started: Mar 28, 2022 · Completed: Jan 26, 2024
5 conditions3 sponsors1 location
NCT05289856
Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
PHASE2Active, not recruiting
30 participants
Started: Mar 28, 2022 · Completed: Dec 1, 2025
1 condition3 sponsors2 locations
NCT05207709
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
PHASE3Active, not recruiting
456 participants
Started: Mar 28, 2022 · Completed: Mar 1, 2027
1 condition3 sponsors71 locations
NCT05262530
Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors
PHASE1/PHASE2Active, not recruiting
73 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor18 locations
NCT05319561
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team
NAActive, not recruiting
8 participants
Started: Mar 28, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor2 locations
NCT05143229
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
PHASE1Active, not recruiting
18 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors7 locations
NCT06879535
Long-term Symptomatic Follow-up of Patients with Long COVID Syndrome
N/AActive, not recruiting
80 participants
Started: Mar 28, 2022 · Completed: Mar 28, 2025
1 condition1 sponsor1 location
NCT05317793
Ambulatory Electrodermal Activity Measurements as Part of Identification and Prevention of Job Burnout
N/AActive, not recruiting
123 participants
Started: Mar 28, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors3 locations
NCT05298904
Pro-active Genetic Testing in Kidney Transplant Patients
N/AActive, not recruiting
177 participants
Started: Mar 28, 2022 · Completed: Mar 1, 2038
1 condition1 sponsor1 location
NCT05301842
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC
PHASE3Active, not recruiting
760 participants
Started: Mar 28, 2022 · Completed: Feb 26, 2027
1 condition1 sponsor171 locations
NCT05337501
Prognostic Factors for Complex Regional Pain Syndrome
NAActive, not recruiting
113 participants
Started: Mar 28, 2022 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT06075446
Calling All Dads! Evaluation of APAs ACT Program: Engaging Fathers to Prevent Adverse Childhood Experiences
N/AActive, not recruiting
500 participants
Started: Mar 28, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05083403
HPI (Hypotension Prediction Index) Care Trial
NAActive, not recruiting
350 participants
Started: Mar 28, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05168384
Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple Sclerosis
PHASE1/PHASE2Active, not recruiting
15 participants
Started: Mar 26, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05155098
2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
N/AActive, not recruiting
127 participants
Started: Mar 25, 2022 · Completed: Aug 29, 2025
4 conditions1 sponsor10 locations
NCT05035459
B-lines-guided Heart Failure Management in Heart Failure Patients
N/AActive, not recruiting
320 participants
Started: Mar 25, 2022 · Completed: Aug 25, 2024
2 conditions1 sponsor1 location
NCT05348577
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)
PHASE3Active, not recruiting
1,035 participants
Started: Mar 25, 2022 · Completed: Mar 4, 2026
1 condition1 sponsor217 locations
NCT04771650
A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users
NAActive, not recruiting
220 participants
Started: Mar 25, 2022 · Completed: Aug 1, 2028
3 conditions4 sponsors2 locations
NCT04769895
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
PHASE3Active, not recruiting
66 participants
Started: Mar 25, 2022 · Completed: Nov 30, 2025
2 conditions1 sponsor50 locations
NCT05224141
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
PHASE3Active, not recruiting
460 participants
Started: Mar 24, 2022 · Completed: Jun 7, 2027
1 condition1 sponsor140 locations
NCT05226598
Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)
PHASE3Active, not recruiting
739 participants
Started: Mar 24, 2022 · Completed: Jan 9, 2026
1 condition1 sponsor149 locations
NCT05286229
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
PHASE1Active, not recruiting
8 participants
Started: Mar 24, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor6 locations
NCT05297708
Office, Home, and Ambulatory Blood Pressure
N/AActive, not recruiting
52 participants
Started: Mar 24, 2022 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT04484441
Maternal-fetal Immune Responses to Fetal Surgery
N/AActive, not recruiting
60 participants
Started: Mar 24, 2022 · Completed: Dec 30, 2025
4 conditions1 sponsor3 locations
NCT05269862
Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation
NAActive, not recruiting
100 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor18 locations
NCT05135559
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
PHASE3Active, not recruiting
153 participants
Started: Mar 24, 2022 · Completed: Nov 2, 2029
1 condition1 sponsor77 locations
NCT05010590
Anabolic Therapy in Postmenopausal Osteoporosis
PHASE4Active, not recruiting
50 participants
Started: Mar 24, 2022 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT05452057
Prehab for Adult Spinal Deformity Surgery
NAActive, not recruiting
24 participants
Started: Mar 24, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05866380
Early Identification of Heart Failure in a High-Risk Diabetic Cohort
N/AActive, not recruiting
3,500 participants
Started: Mar 23, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05316324
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction
PHASE3Active, not recruiting
353 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT05275478
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
PHASE1/PHASE2Active, not recruiting
192 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor20 locations
NCT05297500
Determination of SpO2 and PR Accuracy Specifications At Rest (71Ag_Vital-0031)
N/AActive, not recruiting
12 participants
Started: Mar 23, 2022 · Completed: Mar 29, 2025
1 condition2 sponsors1 location
NCT05213104
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
PHASE3Active, not recruiting
186 participants
Started: Mar 23, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT05662020
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China
PHASE3Active, not recruiting
2,750 participants
Started: Mar 23, 2022 · Completed: Mar 23, 2028
1 condition7 sponsors1 location
NCT05143138
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
N/AActive, not recruiting
259 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor14 locations
NCT05241834
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
PHASE1Active, not recruiting
70 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor16 locations
NCT05297812
Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease
N/AActive, not recruiting
286 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2027
2 conditions3 sponsors9 locations
NCT06339151
Comparing Single Dose and Multiple Dose of Dexamethasone Post TKA
NAActive, not recruiting
120 participants
Started: Mar 23, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05231824
Using Artificial Intelligence to Optimize Delivery of Weight Loss Treatment
NAActive, not recruiting
336 participants
Started: Mar 22, 2022 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05237128
The Lifestyle Education About Nutrition for Diabetes (Legend) Study
NAActive, not recruiting
182 participants
Started: Mar 22, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors2 locations
NCT05144529
A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC
PHASE2Active, not recruiting
38 participants
Started: Mar 22, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05195619
Personalized DC Vaccines in Non Small Cell Lung Cancer
PHASE1Active, not recruiting
16 participants
Started: Mar 22, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05866731
The Heart Rhythm Twins Study
N/AActive, not recruiting
120 participants
Started: Mar 22, 2022 · Completed: Aug 1, 2025
2 conditions1 sponsor1 location
NCT05565313
Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
N/AActive, not recruiting
900 participants
Started: Mar 22, 2022 · Completed: Aug 1, 2026
1 condition3 sponsors3 locations